Immuron

IMRN

IMRN Immuron NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    IMRN Chart
    See on advanced chart >

    About

    Immuron Limited was incorporated under the laws of Australia in 1994. The company is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of...
    Read More
    • Highlight
      An Australian developer of immunomodulator polyclonal antibodies that treats liver disease and infectious diseases
      • Industry
      Pharmaceuticals
    • Exchange
      NASDAQ
    • Listing Date
      06/09/2017
    • Established Date
      Invalid Date
    • Full-time Employees
      7
    • Address
      Level 3 62 Lygon Street Carlton South Victoria 3053 Australia
    • Tel
      61-3-98245254
    • Website
      www.immuron.com
    • Fiscal Year End Date
      06/30
    • Security Type
      American Depositary Receipt (Common Stock)